Page 2 - Greg Korbutt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg korbutt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Korbutt Today - Breaking & Trending Today

Entos Pharmaceuticals Partners with Alberta Cell Therapy Manufacturing and the Ottawa Hospital Research Institute to Manufacture and Ready its COVID-19 DNA Vaccine for Clinical Trials

in the
.
Entos announces partnership with The Ottawa Hospital s Biotherapeutics Manufacturing Centre (BMC) to fill Covigenix VAX-001 in vials.
BMC and ACTM will collaborate to boost Canada s biotherapeutics manufacturing capacity.
EDMONTON, AB, Feb. 25, 2021 /CNW/ - Entos Pharmaceuticals (Entos), a biotechnology company developing genetic medicines with its Fusogenix nucleic acid delivery platform, is excited to work with Alberta Cell Therapy Manufacturing and The Ottawa Hospital s Biotherapeutics Manufacturing Centre to manufacture and ready doses of Entos made-in-Canada Covigenix VAX-001 vaccine for upcoming clinical trials at the Canadian Centre for Vaccinology.
Scientist working in the ACTM facility GMP cleanroom (CNW Group/Entos Pharmaceuticals) ....

Greg Korbutt , Gayle Piat , Duncan Stewart , Johnd Lewis , John Lewis , Entos Pharmaceuticals Inc , Algonquin College , University Of Alberta , Entos Pharmaceuticals , Ottawa Hospital Research Institute , Ontario Research Fund , Ottawa Hospital Foundation , University Of Ottawa , Canadian Centre For Vaccinology , Canada Foundation For Innovation , Ottawa Hospital Biotherapeutics Manufacturing Centre , Alberta Cell Therapy Manufacturing , Health Research Innovation , Ottawa Hospital , Canada Covigenix , Canadian Centre , Executive Vice President , Canada Foundation , Canadian Network , Jenn Ganton , Public Relations ,

CIHR and JDRF funding drives efforts to find new stem cell-based therapies for Type 1 diabetes

Date Time
Share
CIHR and JDRF funding drives efforts to find new stem cell-based therapies for Type 1 diabetes
University of Alberta researchers are among two Canadian research teams chosen for significant new funding from the Government of Canada and JDRF Canada to develop new stem cell-based therapies for treating Type 1 diabetes.
The projects will each receive $1.5 million from the Canadian Institutes of Health Research Institute of Nutrition, Metabolism and Diabetes (CIHR-INMD) along with matching dollars from JDRF Canada, for total funding of $3 million per project over five years. The funding investment marks the anniversary of the Canadian discovery of insulin 100 years ago, a significant turning point in the work to defeat diabetes. ....

United Kingdom , Cristina Maria Nostro , Greg Korbutt , Patrick Macdonald , University Of Toronto , University Of Alberta , Ma Department Of Surgery , University Of British Columbia , Alberta Diabetes Institute , Canadian Institutes , Health Research Institute , Andrew Pepper , Edmonton Protocol , Alberta Cell Therapy Manufacturing , Good Manufacturing Practice Grade , British Columbia , ஒன்றுபட்டது கிஂக்டம் , பேட்ரிக் மெக்டொனால்ட் , பல்கலைக்கழகம் ஆஃப் டொராண்டோ , பல்கலைக்கழகம் ஆஃப் ஆல்பர்ட்டா , பல்கலைக்கழகம் ஆஃப் பிரிட்டிஷ் கொலம்பியா , ஆல்பர்ட்டா நீரிழிவு நோய் நிறுவனம் , கனடியன் நிறுவனங்கள் , ஆரோக்கியம் ஆராய்ச்சி நிறுவனம் , ஆண்ட்ரூ மிளகு , எட்மண்டன் ப்ரோடொகால் ,